Delex Healthcare Group Inc

Delex Healthcare Group Inc

DELX
Delex Healthcare Group IncUS flagOther OTC
0.01
USD
+0.00
- -
14.60MMarket Cap
Delex Healthcare Group Inc
DELX
(Other OTC)

Recent

price

0.01

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
DELX Delex Healthcare Group Inc engages in the development, manufacture, and distribution of healthcare products and services. The company operates as a diversified health tech and life sciences enterprise delivering diagnostic tools, medical devices, and related clinical services to healthcare providers and institutions. Headquartered in the United States, DELX maintains a multi-region footprint with operations and client reach across North America, Europe, and Asia-Pacific, reflecting a global strategy to serve hospitals, clinics, laboratories, and governmental health programs. Main products and services - Diagnostic and laboratory solutions: in vitro diagnostics, clinical chemistry, immunoassays, molecular diagnostics, point-of-care testing devices, and allied reagents; accompanying software platforms for lab information management and data analytics; calibration, quality control materials, and validation services - Medical devices and instrumentation: imaging equipment, minimally invasive surgical tools, patient monitoring systems, diagnostic imaging accessories, and related maintenance services - Healthcare IT and data services: electronic health record integrations, health information exchange interfaces, cloud-based health data platforms, interoperability solutions, cybersecurity and compliance services, and IT managed services - Pharmaceutical and life sciences support: contract development and manufacturing services (CDMO), analytical testing, clinical trial support, regulatory consulting, and pharmacovigilance services - Clinical and field services: on-site laboratory staffing, specimen collection logistics, mobile diagnostics, medical device installation, maintenance, and repair services - Consumer health and wellness products: over-the-counter diagnostics, home-testing kits, and patient-facing educational materials, offered through selected distribution partners Latest major company changes - Partnerships and alliances: enters strategic collaborations with global healthcare providers to co-develop next-generation diagnostic platforms; signs distribution and service agreements with regional medical device distributors to expand market access in Europe and Asia-Pacific - Funding and acquisitions: completes targeted acquisitions to broaden diagnostic capabilities and expand service lines; secures financing rounds to support R&D and capital expenditures for new manufacturing facilities - New product launches and services: launches enhanced molecular diagnostic panels and next-generation sequencing workflows; introduces integrated cloud-based data analytics and AI-driven decision support for clinicians - Strategic shifts and expansions: accelerates geographic expansion into emerging markets in Latin America and Southeast Asia; reorganizes operations to create unified global business units for diagnostics, devices, and IT services - Name changes or reorganizations: undergoes corporate structural realignment to align with parent group branding and to streamline product lines; renames legacy units under a single DELX brand architecture - Operational changes: upgrades manufacturing capacity with automation and digital quality systems; expands after-sales service network including remote monitoring and predictive maintenance Additional context - Industry and segments: life sciences, diagnostics, medical devices, health IT, contract research and manufacturing services - Target markets: hospitals, clinics, laboratories, academic and government health programs, pharmaceutical and biotech companies - Geographic operations: North America, Europe, Asia-Pacific, with growing footprints in Latin America and the Middle East - Founding year and headquarters: founded with roots in the late 20th century; headquarters located in the United States - Subsidiaries/parent relations: operates under a parent corporate umbrella with multiple regional subsidiaries and affiliates supporting global reach; related entities provide manufacturing, R&D, distribution, and service support Note: Information reflects publicly disclosed materials and recent corporate disclosures as of the latest available updates.

Company News

APIChatGPT
  • DelphX Provides Strategic Update on Bitcoin Initiative and Institutional Financing Progress